Clinical Trial Update: Safety and Efficacy of VEC-162 on Circadian Rhythm in Healthy Adult Volunteers [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of VEC-162 for circadian rhythm sleep disorders in healthy adult volunteers. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Circadian Rhythm Sleep Disorders

Drugs mentioned

• VEC-162

Snippet

Sponsor: Vanda Pharmaceuticals | Conditions: Circadian Rhythm Sleep Disorders | Phase 2 | Status: COMPLETED | Results posted: 2014-08-26